Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy
Acta Biomaterialia · 2023-09 · 167 · 121-134
DOI: 10.1016/j.actbio.2023.06.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2023-09. Verfasst von Chrysovalantis Voutouri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Cyprus. Hauptthemen laut MEDLINE: Melanoma, Elasticity Imaging Techniques. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Horizon 2020, European Regional Development Fund, University of Cyprus.
Abstract (Originalsprache)
Immunotherapy has revolutionized the treatment of dozens of cancers and became a standard of care for some tumor types. However, the majority of patients do not benefit from current immunotherapeutics and many develop severe toxicities. Therefore, the identification of biomarkers to classify patients as likely responders or non-responders to immunotherapy is a timely task. Here, we test ultrasound imaging markers of tumor stiffness and perfusion. Ultrasound imaging is non-invasive and clinically available and can be used both for stiffness and perfusion evaluation. In this study, we employed syngeneic orthotopic models of two breast cancers, a fibrosarcoma and a melanoma, to demonstrate that ultrasound-derived measures of tumor stiffness and perfusion (i.e., blood volume) correlate with the efficacy of immune checkpoint inhibition (ICI) in terms of changes in primary tumor volume. To modulate tumor stiffness and perfusion and thus, get a range of therapeutic outcomes, we employed the mechanotherapeutic tranilast. Mechanotherapeutics combined with ICI are advancing through clinical trials, but biomarkers of response have not been tested until now. We found the existence of linear correlations between tumor stiffness and perfusion imaging biomarkers as well as strong linear correlations between the stiffness and perfusion markers with ICI efficacy on primary tumor growth rates. Our findings set the basis for ultrasound biomarkers predictive of ICI therapy in combination with mechanotherapeutics. STATEMENT OF SIGNIFICANCE: Hypothesis: Monitoring Tumor Microenvironment (TME) mechanical abnormalities can predict the efficacy of immune checkpoint inhibition and provide biomarkers predictive of response. Tumor stiffening and solid stress elevation are hallmarks of tumor patho-physiology in desmoplastic tumors. They induce hypo-perfusion and hypoxia by compressing tumor vessels, posing major barriers to immunotherapy. Mechanotherapeutics is a new class of drugs that target the TME to reduce stiffness and improve perfusion and oxygenation. In this study, we show that measures of stiffness and perfusion derived from ultrasound shear wave elastography and contrast enhanced ultrasound can provide biomarkers of tumor response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Cyprus.
- Department of Bioengineering, University of Washington, Seattle, WA, United States.
- Materia Therapeutics, Las Vegas, NV, United States.
- Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Cyprus. Electronic address: tstylian@ucy.ac.cy.
Förderung
- Horizon 2020
- European Regional Development Fund
- University of Cyprus
- Research and Innovation Foundation
- European Research Council
Zitieren
APA
Voutouri, C., Mpekris, F., Panagi, M., Krolak, C., Michael, C., Martin, J. D., Averkiou, M. A., & Stylianopoulos, T. (2023). Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy. Acta Biomaterialia, 167, 121-134. https://doi.org/10.1016/j.actbio.2023.06.007
Vancouver
Voutouri C, Mpekris F, Panagi M, Krolak C, Michael C, Martin JD, et al. Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy. Acta Biomaterialia. 2023;167:121-134. doi:10.1016/j.actbio.2023.06.007
BibTeX
@article{Voutouri2023,
author = {Voutouri, Chrysovalantis and Mpekris, Fotios and Panagi, Myrofora and Krolak, Connor and Michael, Christina and Martin, John D and Averkiou, Michalakis A and Stylianopoulos, Triantafyllos},
title = {Ultrasound stiffness and perfusion markers correlate with tumor volume responses to immunotherapy},
journal = {Acta Biomaterialia},
year = {2023},
volume = {167},
pages = {121--134},
doi = {10.1016/j.actbio.2023.06.007}
}
EUVIMED